NCT06351605 - A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT) | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions

Dry Age-related Macular Degeneration

Interventions

DEVICE

Valeda Light Delivery System

The Valeda Light Delivery System will deliver two alternating and sequential treatments of 590 nm and 850 nm for 35 seconds, or a total of 70 seconds; and 660 nm for 90 seconds, or a total of 180 seconds.

Trial Locations (1)

Unknown

RECRUITING

Oslo University Hospital, Oslo